SENSEX NIFTY

Ranbaxy Laboratories

May 09, 2016 at 15:18 | Source: CNBC-TV18
Joint inspections with eight other regulators carried at six of Ranbaxys laboratories in Himachal Pradesh found discrepancies in testing, stability standards and expiry dates, among other standards.
May 05, 2016 at 20:47 | Source: CNBC-TV18
Malvinder and Shivinder Singh had sold their stake in Ranbaxy Laboratories to Daiichi way back in 2008, following which Daiichi-led Ranbaxy was forced to pay the US Department of Justice a sum of USD 500 million over non-compliance with US Food and Drug Administration's testing norms.
Apr 04, 2016 at 19:50 | Source: PTI
The Supreme Court today directed the government to reply in two weeks on a plea seeking cancellation of licence issued to Ranbaxy Laboratories Ltd forallegedly selling substandard drugs in India.
Mar 07, 2016 at 12:26 | Source: Reuters
Three years ago, Dinesh Thakur exposed how India's then largest drugmaker and his former employer, Ranbaxy Laboratories, failed to conduct proper safety and quality tests on drugs and lied to regulators about its procedures.
Jan 22, 2016 at 19:05 | Source: PTI
Last year in September, Sun Pharma and Strides Shasun (then Strides Arcolab) had inked a pact related to Ranbaxy's 'Solus' and 'Solus Care' divisions operating in the central nervous system (CNS) segment in India.
Oct 28, 2015 at 20:15 | Source: PTI
As per the information available on the USFDA website, Ohm Laboratories Inc, a unit of Ranbaxy Laboratories, which the company acquired last year, is recalling 10,85,095 boxes for being "Superpotent Drug: Out Of Specification".
Oct 11, 2015 at 11:27 | Source: PTI
The government is likely to commission a study soon to assess the impact of foreign direct investment in existing pharmaceutical companies in view of concerns expressed on the issue by a Parliamentary panel.
Oct 09, 2015 at 08:36 | Source: Moneycontrol.com
Sun Pharmaceutical Industries Ltd has informed BSE that the Company has withdrawn its appeal in the lawsuit filed by erstwhile Ranbaxy Laboratories Limited (Ranbaxy) in November 2014 in a US District Court against U.S. Food and Drug Administration (FDA).
Sep 24, 2015 at 16:42 | Source: CNBC-TV18
Prakash Diwan of prakashdiwan.in is of the view that Lupin may test Rs 2600-2700.
Sep 24, 2015 at 13:25 | Source: CNBC-TV18
Deepak Shenoy of capitalmind.in has a positive stance on Sun Pharmaceutical Industries and Strides Arcolab.
Messages on Ranbaxy Laboratories »

BSE/NSE Announcer

Platinum Member

16518 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has informed BSE that a meeting of the Board of Directors of the Company will be held on February 26, 2013, inter alia, to consider and approve Audited Financial Results for the quarter and financial year ended December 31, 2012.

5.05 PM Jan 29th 2013

usha91

New Member

0 Follower

Services - Sector  

Ranbaxy Laboratories

3.39 PM Jan 23rd 2013

Market Statistician

Platinum Member

18379 Followers

Ranbaxy Labs  

At 15:14 hrs, Ranbaxy Laboratories was trading at Rs 498.50 down 0.26%, with a huge increase in its volume of shares traded. Till now over 158,019 shares were traded as compared to its 5-day average of 69,355 shares.

3.15 PM Dec 14th 2012

Stock Advisor

Platinum Member

1123 Followers

Infosys  

Prabhudas Lilladher has come out with its report on "India strategy & top ideas". Infosys, ICICI Bank, Wipro, Cairn India, Power Grid Corporation, Dr.Reddy`s Laboratories, Adani Port & SEZ and Ranbaxy Laboratories are the stocks from large cap space

7.12 PM Dec 7th 2012

Web Messenger

Platinum Member

362379 Followers

Ranbaxy Labs  

Source:Business Standard - Malvinder Mohan Malav Singh, when he owned and ran Ranbaxy Laboratories (the Singh family sold the pharmaceutical company to Daiichi Sankyo of Japan in 2008; Malav exited the company a year later), would often say with pride the company had done the maximum overseas

12.46 PM Dec 6th 2012

trader555

Gold Member

6 Followers

Ranbaxy Labs  

Buy Ranbaxy Laboratories at 511 t1 525 t2 560 stop loss at 504

8.42 PM Dec 5th 2012

shareselect

Silver Member

31 Followers

Ranbaxy Labs  

Ranbaxy Laboratories looks attractive to start buying on dips with a short-to-medium term view. Current Market Price is Rs. 512.05 in BSE.

8.16 PM Dec 4th 2012

MMB Messenger

Platinum Member

368888 Followers

Ranbaxy Labs  

Will you bet on Ranbaxy Laboratories for long term?

11.37 AM Dec 4th 2012

Web Messenger

Platinum Member

362379 Followers

Ranbaxy Labs  

Source:DNA India - Drugmaker Ranbaxy Laboratories has stopped production of its generic version of cholesterol lowering drug Lipitor until it investigates the issue of contamination in certain lots, US health regulator said. Batches of the company s 10mg, 20mg and 40mg tablets of the drug were

5.10 PM Dec 1st 2012

Web Messenger

Platinum Member

362379 Followers

Ranbaxy Labs  

Source:Business Today - Ranbaxy Laboratories has stopped production of its generic version of cholesterol lowering drug Lipitor until it investigates the issue of potential glass particles in certain lots, the US health regulator has said.The Indian drug major on November 9 had informed its

4.27 PM Dec 1st 2012

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.